Latest Breaking News On - Michelle greenblatt - Page 5 : comparemela.com

argenx Announces U S Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

United statesUnited kingdomKelsey kirkMichelle greenblattHoward jf jrBeth delgiaccoExchange commissionZai labDrug administrationImmunology innovation programMyasthenia gravisDaily livingImportant safety informationPrescribing informationNorth americaTherapeutics targets

argenx SE: argenx Announces U S Food and Drug Administration (FDA) Approval of VYVGART (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

VYVGART is the first-and-only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients treated with VYVGART were responders (n=44/65)

United statesUnited kingdomMichelle greenblattSamantha mastersonKelsey kirkJamesf howard jrHoward jf jrSteve millerBeth delgiaccoVan hauwermeirenTim van hauwermeirenDepartment of neurologyZai labDrug administrationExchange commissionMyasthenia gravis foundation of america

argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings

argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace

United statesChafic karamMichelle greenblattGregoryw fultonDemyelinating polyneuropathyJeffrey guptillGlenn phillipsKelsey kirkNicholasj silvestriWim parysGil wolfePeter donofrioTuan vuBeth delgiaccoNeelam goyalUniversity health network

argenx to Present at Upcoming Investor Conferences

argenx to Present at Upcoming Investor Conferences
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKelsey kirkMichelle greenblattBeth delgiaccoLife sciences biotech virtual conferenceImmunology innovation programBiotech virtualStanley global healthcareGlobal healthcareCyberx seriesRare diseasesGenetic medicines

argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in

argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesKelsey kirkMichelle greenblattBeth delgiaccoTim van hauwermeirenAndreas meiselDepartment of neurologyDrug administrationEuropean medicines agencyDevices agencyJapan pharmaceuticalsImmunology innovation programChief executive officerSenior physicianMyasthenia gravis outpatient clinicPrincipal investigator